Patients treated prophylactically with micafungin were those undergoing haematopoetic stem cell transplantation (HSCT) who were at high risk for fungal infections.
Mikafungiini profülaktiliselt saanud patsiendid olid need, kellele tehti vereloome tüvirakkude siirdamine ja kellel oli suur risk seeninfektsioonide tekkeks.